{"CORX": {"short_name": "CORE LITHIUM CORP", "long_name": "Core Lithium Corp.", "summary": "Core Lithium Corp., an exploration stage mining company, engages in the identification, acquisition, exploration, mining, and development of lithium assets in North America. Its principal property is the Quadra lithium claims property, which consists of 56 mineral exploration titles covering an area of approximately 7,840 acres located in the James Bay region of Northern Quebec, Canada. The company was formerly known as All American Energy Corp. and changed its name to Core Lithium Corp. in April 2018. Core Lithium Corp. was incorporated in 1994 and is based in Cincinnati, Ohio.", "currency": "USD", "sector": "Healthcare", "industry": "Drug Manufacturers - Other", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Cincinnati"}, "PRTX": {"short_name": "PROTALEX INC", "long_name": "Protalex, Inc.", "summary": "Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase 1b clinical trial for the treatment of RA on methotrexate or leflunomide. The company was founded in 1999 and is based in Florham Park, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Drug Manufacturers - Other", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Florham Park"}}